DeepMind’s new AlphaGenome AI tackles the ‘dark matter’ in our DNA

Tool aims to solve the mystery of non-coding sequences — but is still in its infancy.

Nearly 25 years after scientists completed a draft human genome sequence, many of its 3.1 billion letters remain a puzzle. The 98% of the genome that is not made of protein-coding genes — but which can influence their activity — is especially vexing.


An artificial intelligence (AI) model developed by Google DeepMind in London could help scientists to make sense of this ‘dark matter’, and see how it might contribute to diseases such as cancer and influence the inner workings of cells. The model, called AlphaGenome, is described in a 25 June preprint.

“This is one of the most fundamental problems not just in biology — in all of science,” said Pushmeet Kohli, the company’s head of AI for science, at a press briefing.


The ‘sequence to function’ model takes long stretches of DNA and predicts various properties, such as the expression levels of the genes they contain and how those levels could be affected by mutations.


“I think it is an exciting leap forward,” says Anshul Kundaje, a computational genomicist at Stanford University in Palo Alto, California, who has had early access to AlphaGenome. “It is a genuine improvement in pretty much all current state-of-the-art sequence-to-function models.”


Link to full article:  https://www.nature.com/articles/d41586-025-01998-w



Share this Article with others

By Sorena Nadaf June 6, 2025
Cancer Center Informatics Society Working Group Announcement and Endorsement of the American Center for Cures
By Sorena Nadaf April 17, 2025
Caught in the crossfire: The critical threats facing cancer centers, research, and patient care. Shannon McWeeney PhD, & Sorena Nadaf-Rahrov MS, MMI
By Sorena Nadaf February 13, 2025
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
By Sorena Nadaf February 5, 2025
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
By Sorena Nadaf September 4, 2024
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
September 4, 2024
Leading Progress Against Cancer